Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000117708 | SCV000167460 | benign | not specified | 2012-05-03 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000676286 | SCV001732041 | benign | not provided | 2025-01-20 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001527303 | SCV001738266 | benign | Mitochondrial complex 1 deficiency, nuclear type 16 | 2021-06-10 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000676286 | SCV005312372 | benign | not provided | criteria provided, single submitter | not provided | ||
Genetic Services Laboratory, |
RCV000117708 | SCV000151955 | likely benign | not specified | no assertion criteria provided | clinical testing | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. | |
Mayo Clinic Laboratories, |
RCV000676286 | SCV000802042 | benign | not provided | 2016-02-29 | no assertion criteria provided | clinical testing | |
Natera, |
RCV001275554 | SCV001460794 | benign | Leigh syndrome | 2020-09-16 | no assertion criteria provided | clinical testing |